Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.
Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.
Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
Should patients with optic neuritis be treated with steroids?
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling.
Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
A case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion.
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
Peptide immunotherapy in experimental autoimmune encephalomyelitis.
Cardiovascular Dysfunction in Multiple Sclerosis.
Evidence of aquaporin involvement in human central pontine myelinolysis.
Cortical plasticity predicts recovery from relapse in multiple sclerosis.
Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.
OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.
Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese population.
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice.]
A study on the direct and indirect costs of multiple sclerosis based on expanded disability status scale score in khuzestan, iran.
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
Modeling cognition and disease using human glial chimeric mice.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Pages
« first
‹ previous
…
644
645
646
647
648
649
650
651
652
…
next ›
last »